JP2024542126A5 - - Google Patents

Info

Publication number
JP2024542126A5
JP2024542126A5 JP2024526788A JP2024526788A JP2024542126A5 JP 2024542126 A5 JP2024542126 A5 JP 2024542126A5 JP 2024526788 A JP2024526788 A JP 2024526788A JP 2024526788 A JP2024526788 A JP 2024526788A JP 2024542126 A5 JP2024542126 A5 JP 2024542126A5
Authority
JP
Japan
Application number
JP2024526788A
Other languages
Japanese (ja)
Other versions
JP2024542126A (ja
JPWO2023081935A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079505 external-priority patent/WO2023081935A2/en
Publication of JP2024542126A publication Critical patent/JP2024542126A/ja
Publication of JP2024542126A5 publication Critical patent/JP2024542126A5/ja
Publication of JPWO2023081935A5 publication Critical patent/JPWO2023081935A5/ja
Pending legal-status Critical Current

Links

JP2024526788A 2021-11-08 2022-11-08 自己増幅rna組成物及びその使用方法 Pending JP2024542126A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163277116P 2021-11-08 2021-11-08
US63/277,116 2021-11-08
PCT/US2022/079505 WO2023081935A2 (en) 2021-11-08 2022-11-08 Self-amplifying rna compositions and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024542126A JP2024542126A (ja) 2024-11-13
JP2024542126A5 true JP2024542126A5 (https=) 2025-11-17
JPWO2023081935A5 JPWO2023081935A5 (https=) 2025-11-17

Family

ID=86242092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526788A Pending JP2024542126A (ja) 2021-11-08 2022-11-08 自己増幅rna組成物及びその使用方法

Country Status (9)

Country Link
US (1) US20250108105A1 (https=)
EP (1) EP4430200A4 (https=)
JP (1) JP2024542126A (https=)
KR (1) KR20240099240A (https=)
CN (1) CN118382701A (https=)
AU (1) AU2022380858A1 (https=)
CA (1) CA3236959A1 (https=)
IL (1) IL312557A (https=)
WO (1) WO2023081935A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3236959A1 (en) * 2021-11-08 2023-05-11 Sue-Jean HONG Self-amplifying rna compositions and methods of use thereof
CN120082547B (zh) * 2025-05-06 2025-10-03 北京悦康科创医药科技股份有限公司 用于自复制mRNA的加帽类似物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2943221A1 (en) * 2013-01-10 2015-11-18 Novartis AG Influenza virus immunogenic compositions and uses thereof
BR112018069417A2 (pt) * 2016-04-22 2019-01-22 Biontech Rna Pharmaceuticals Gmbh método para fornecer rna fita simples e ssrna
US10967057B2 (en) * 2016-06-02 2021-04-06 Glaxosmithkline Biologicals S.A. Zika viral antigen constructs
WO2021216776A2 (en) * 2020-04-21 2021-10-28 Gritstone Bio, Inc. Capping compounds, compositions and methods of use thereof
CA3236959A1 (en) * 2021-11-08 2023-05-11 Sue-Jean HONG Self-amplifying rna compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
CN307046654S (https=)
BY13135U (https=)
BY13137U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
CN307045488S (https=)